Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials.

Pollyea, Daniel A; Gutman, Jonathan A; Gore, Lia; Smith, Clayton A; Jordan, Craig T

Pollyea, Daniel A; Gutman, Jonathan A; Gore, Lia; Smith, Clayton A; Jordan, Craig T.

Affiliation

Pollyea DA; Division of Hematology, University of Colorado School of Medicine, Aurora, CO.
Gutman JA; Division of Hematology, University of Colorado School of Medicine, Aurora, CO.
Gore L; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.
Smith CA; Division of Hematology, University of Colorado School of Medicine, Aurora, CO.
Jordan CT; Division of Hematology, University of Colorado School of Medicine, Aurora, CO craig.jordan@ucdenver.edu.

Haematologica ; 99(8): 1277-84, 2014 Aug.

Article in En | MEDLINE | ID: mdl-25082785

Subject(s)

Antineoplastic Agents/administration & dosage; Drug Delivery Systems/methods; Leukemia, Myeloid, Acute/drug therapy; Neoplastic Stem Cells/drug effects; Clinical Trials as Topic/methods; Clinical Trials as Topic/trends; Drug Delivery Systems/trends; Humans; Leukemia, Myeloid, Acute/diagnosis; Neoplastic Stem Cells/pathology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Neoplastic Stem Cells / Leukemia, Myeloid, Acute / Drug Delivery Systems / Antineoplastic Agents Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Haematologica Year: 2014 Type: Article Affiliation country: Colombia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google